|
Market Closed -
Other stock markets
|
Pre-market 08:23:23 | |||
| 695.18 USD | +4.20% |
|
670.21 | -3.59% |
| 07-24 | US FDA approves Outlook Therapeutics' eye disease drug | RE |
| 07-24 | Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | +4.20% | +2.96% | -9.94% | +24.44% | +18.55% | 70.73B |  |  | |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
